| 9683-03-21 | ||||
| 9683-03-07 | ||||
| 8184-02-14 | ||||
| 6832-03-19 | ||||
| 5367-02-26 | ||||
| 3996-03-31 | ||||
| 2524-03-09 | ||||
| 2012-08-15 | Reiterated | UBS | Buy | $22 to $16 |
| 2012-03-28 | Reiterated | UBS | Buy | $25 to $22 |
| 2011-12-15 | Upgrade | Robert W. Baird | Underperform to Neutral | $10 |
| 1970-01-01 |
| 9683-03-21 | ||||
| 9683-03-07 | ||||
| 8184-02-14 | ||||
| 6832-03-19 | ||||
| 5367-02-26 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In KIOR 0 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Peterson Stuart L | 8.79% (5634297) | KIOR / |
| O'Connor Paul | 3.71% (2378421) | KIOR / |
| Artis Partners 2X Ltd | 3.51% (2248680) | KIOR / |
| BIOeCON B.V. | 3.33% (2135000) | KIOR / |
| Cannon Fred President and CEO | 0.95% (606997) | KIOR / |
| KARNES JOHN H JR Chief Financial Officer | 0.17% (109546) | KIOR / |
| Kasbaum John Senior VP of Commercial | 0.17% (108348) | KIOR / |
| Artzer Christopher A VP,General Counsel & Secretary | 0.15% (95296) | KIOR / |
| Kaul Samir | 0.11% (69479) | GEVO / KIOR / |
| WHITLOCK GARY L | 0.10% (66300) | CNP / ENBL / KIOR / |
| PATERSON DAVID J | 0.10% (64285) | KIOR / VRS / |
| Roach William J. | 0.08% (52240) | KIOR / |
| Lyle W. Roger SVP of Operations | 0.07% (42098) | KIOR / |
| LELAND D MARK | 0.05% (31942) | DEL / EPB / KIOR / OILT / |